Decision Aid Summary

Title Cholinesterase inhibitors to reduce the symptoms of Alzheimer's disease ; Les inhibiteurs de la cholinestérase pour réduire les symptômes de la maladie d'Alzheimer
Audience Clinicians presenting information about taking medication for Alzheimer’s disease to patients and carers.
Options included Taking cholinesterase inhibitors (donepezil, rivastigmine and galantamine).
Not taking cholinesterase inhibitors.
Year of last update or review 2011
Format Web, paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer Anik Giguère
Where was it developed? www.decisionbox.ulaval.ca
Université Laval
Canada
Health condition Alzheimer's disease
Type of decision aid Treatment
Language English, French
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
6 out of 7 criteria to be defined as a patient decision aid
8 out of 9 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2017-04-06.